Approval · Notice of Compliance 8629 · 2007
ISOPTIN SR: Notice of Compliance 8629
Issued March 1, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8629
- Date
- March 1, 2007
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the drug interactions section of the product monograph and other revisions to the product monograph
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ISOPTIN SR | Not yet assigned | — |
Medicinal ingredients
- VERAPAMIL HCL 120 MG per TAB
- VERAPAMIL HCL 180 MG per TAB
- VERAPAMIL HCL 240 MG per TAB